(Q35368049)

English

Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

atrial fibrillation

1 reference

based on heuristic

inferred from title

author name string

Vos MA

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Golitsyn SR

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Stangl K

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Ruda MY

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Van Wijk LV

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Harry JD

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Perry KT

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Touboul P

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Steinbeck G

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Wellens HJ

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

568-575

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Concurrent compliance reduction and increased peripheral resistance in the manifestation of isolated systolic hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728725

12 July 2018

Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique ionic mechanism of action of ibutilide on freshly isolated heart cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiological remodeling of the heart owing to rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10078083

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35368049&oldid=1594897163"